Accelerating Discovery, Compliance & Care with Automation
Years of Expertise in Automation
Reduction in Manual Processing Time
Average ROI Per Automation Achieved
Accuracy in Automated Data Entry
What Is Life Sciences Automation?
Life sciences automation refers to the deployment of intelligent software including Robotic Process Automation (RPA), Agentic AI, Machine Learning, and Intelligent Document Processing (IDP) to execute high-volume, precision-critical, and heavily regulated workflows across pharmaceutical companies, biotechnology firms, medical device manufacturers, contract research organisations, and clinical development teams without manual intervention. From drug development and clinical trial management to regulatory submissions, pharmacovigilance, and manufacturing quality control, automation is rapidly becoming the operational backbone of competitive and compliant life sciences organisations.
Modern life sciences automation goes far beyond simple task scripting. Today’s solutions leverage Agentic AI that can reason through complex regulatory requirements, adapt to evolving FDA, EMA, and ICH guideline frameworks, and make autonomous data processing decisions within validated, audit-ready boundaries enabling pharmaceutical companies, biotech startups, CROs, and MedTech manufacturers to accelerate time-to-market, reduce compliance risk, and operate clinical and commercial operations at unprecedented scale.
At Automate Stacks, we design and deploy end-to-end life sciences automation solutions built for the strict GxP compliance, data integrity, validation, and regulatory submission requirements of the pharmaceutical and life sciences sector. Whether you need to automate clinical data collection, streamline regulatory document management, build intelligent pharmacovigilance workflows, or accelerate manufacturing batch record processing, our team delivers measurable ROI from the first validated deployment.
Core Technologies Life Sciences Automation
Robotic Process Automation (RPA)
Clinical data entry, regulatory submissions, batch record processing, audit trail generation
Agentic AI & LLMs
Adverse event narrative generation, protocol deviation assessment, regulatory query responses
Hyperautomation
End-to-end orchestration of R&D, clinical, regulatory, and commercial operations workflows
Intelligent Document Processing (IDP)
eCTD modules, CRFs, safety reports, clinical study reports, manufacturing SOPs, batch records
Machine Learning
Signal detection in pharmacovigilance, clinical trial site selection, supply chain demand forecasting
Workflow Orchestration
Cross-functional GxP process governance, deviation management, CAPA tracking, audit readiness
Key Use Cases: Life Sciences Automation
Automate Stacks has deployed life sciences automation solutions across global pharmaceutical companies, biotech firms, medical device manufacturers, and contract research organisations. Below are the highest-impact areas where our life sciences clients achieve transformational operational and compliance results.
- Clinical Trial Data Management & EDC Automation
Clinical trial data management is among the most labour-intensive and precision-critical processes in drug development. Manual data entry, query management, and cross-system reconciliation across Electronic Data Capture systems, CTMS, and laboratory platforms consume CRA and data management resources that should be focused on study quality and patient safety. Our clinical data automation solutions use RPA and AI to:
- Automate patient data transcription from source documents and ePRO systems into EDC platforms, Medidata Rave, Oracle Clinical One, Veeva Vault CDMS with validation rule enforcement
- Automated data query generation and tracking raising queries for missing, out-of-range, and inconsistent data points and tracking resolution workflows to closure
- Discrepancy detection automation, cross-validating EDC data against CTMS, LIMS, and central laboratory data feeds to identify protocol deviations and data inconsistencies
- Automated CRF completion monitoring, generating site performance metrics, data entry lag reports, and outstanding query dashboards for clinical operations teams
- Database lock preparation automation, running pre-lock data quality checks, generating outstanding query reports, and coordinating sign-off workflows across biostatistics and data management
- Regulatory-grade audit trail maintenance across all automated data handling activities to support 21 CFR Part 11 and ICH E6 GCP compliance
- Regulatory Affairs & Submission Automation
Regulatory submissions are among the most document-intensive and deadline-critical processes in life sciences. Manual compilation of eCTD dossiers, management of regulatory correspondence, and tracking of submission timelines across multiple agencies and products consume significant regulatory affairs resources while creating material risk of submission errors and missed deadlines. Our regulatory automation solutions cover:
- Automated eCTD document compilation, aggregating clinical study reports, module documents, and supporting data into structured submission-ready packages
- Regulatory intelligence monitoring automation, tracking FDA, EMA, MHRA, TGA, and ICH guideline updates and alerting regulatory teams to changes affecting active submissions
- Health authority query response management, tracking incoming agency questions, assigning response owners, monitoring deadlines, and compiling response packages
- Variation and post-approval change management automation, tracking committed variations, generating submission timelines, and coordinating cross-functional review workflows
- Regulatory submission tracking across markets, monitoring approval status, label negotiations, and lifecycle management milestones across global regulatory portfolios
- Label management automation, tracking country-specific labelling requirements, coordinating translations, and managing label version control across the product lifecycle
- Pharmacovigilance & Drug Safety Automation
Pharmacovigilance operations involve processing thousands of adverse event reports, generating ICSRs, conducting aggregate safety analyses, and submitting expedited reports to regulators within strict statutory timeframes. Manual safety case processing is resource-intensive and carries serious regulatory consequence when reporting deadlines are missed. Our pharmacovigilance automation solutions enable:
- Automated adverse event intake, processing incoming safety reports from clinical trials, literature surveillance, social media monitoring, and spontaneous reporting sources
- ICSR data entry and narrative generation automation, extracting structured patient, event, and drug data and generating case narratives using AI-assisted writing tools
- Automated seriousness, expectedness, and causality assessment support, applying pre-defined assessment criteria and flagging cases requiring medical review
- Expedited report generation and regulatory submission automation, producing 15-day ICSRs, 7-day fatal/life-threatening reports, and submitting via E2B(R3) to EudraVigilance, FDA FAERS, and other safety databases
- Aggregate safety reporting automation, compiling PSUR, DSUR, and PBRER data from validated sources and generating structured report sections
- Signal detection workflow automation, processing disproportionality analysis outputs and routing potential safety signals to pharmacovigilance medical review teams
- Manufacturing Quality & GMP Compliance Automation
Pharmaceutical and MedTech manufacturing quality operations generate vast volumes of documentation batch records, deviation reports, change controls, CAPA records, and environmental monitoring data all subject to GMP requirements and regulatory inspection readiness obligations. Manual quality management processes create compliance risk and consume QA resources that should focus on quality oversight rather than data entry.
- Electronic batch record processing automation, extracting yield, in-process control, and analytical data and populating validated batch record templates with automated exception flagging
- Deviation and OOS investigation workflow automation, routing deviations to the correct investigation team, tracking investigation timelines, and escalating overdue actions to quality management
- CAPA management automation, generating CAPA records from approved deviations, tracking effectiveness check schedules, and monitoring overdue CAPA closure commitments
- Change control workflow orchestration, routing change requests through cross-functional review, tracking regulatory impact assessments, and managing approval workflows
- Environmental monitoring data aggregation and trending automation, collecting cleanroom monitoring data and generating exceedance alerts and trend analysis reports
- Supplier qualification and audit management automation, tracking supplier qualification status, audit schedules, and corrective action response timelines
- Clinical Supply Chain & Inventory Automation
Clinical supply chain management ensuring the right investigational medicinal product reaches the right site at the right time is operationally complex and failure-critical. Manual depot inventory management, site resupply request processing, and IMP shipment tracking create supply disruptions that delay patient dosing and compromise trial integrity.
- Automated clinical site inventory monitoring, tracking IMP stock levels against resupply thresholds and triggering automated resupply requests to clinical depots
- Shipment tracking automation, monitoring IMP shipment status from depot dispatch through customs clearance to site delivery confirmation with automated alert escalation
- Temperature excursion monitoring and automated response workflows, processing cold chain monitoring data and triggering quality review processes for out-of-range events
- Expiry and re-test date management automation, tracking IMP shelf life across depots and sites, generating destruction requests, and coordinating replacement shipments
- IRT/RTSM integration automation, synchronising randomisation data, kit dispensing records, and site inventory status between IRT systems and supply chain management platforms
- Clinical supply forecasting automation, modelling protocol-driven demand based on enrolment projections, visit schedules, and dosing regimens to optimise manufacturing and packaging campaigns
- Medical Affairs & Post-Market Surveillance Automation
Medical affairs and post-market surveillance teams manage vast volumes of scientific literature, medical information requests, healthcare professional interactions, and post-market safety data across approved products. Manual literature monitoring, MIR response management, and PMS data compilation are major resource sinks that intelligent automation can transform.
- Systematic literature review automation, automated PubMed, Embase, and clinical trial registry screening, deduplication, and relevance classification against search strategies
- Medical information request intake and response automation capturing, HCP queries across channels, routing to the correct therapeutic area team, and tracking response timelines
- KOL interaction tracking and CRM data entry automation, logging medical affairs engagement activities, conference interactions, and advisory board outputs into medical CRM systems
- Post-market clinical follow-up data aggregation, collecting real-world evidence, registry data, and post-market study results for periodic safety update compilation
- Scientific communication review and approval workflow automation, routing publications, congress abstracts, and scientific materials through medical-legal-regulatory review processes
- Complaint management automation, processing product technical complaints, routing to quality investigations, and coordinating regulatory reporting where threshold criteria are met
- Finance, Procurement & Back-Office Automation
Life sciences organisations manage complex procurement, accounts payable, and financial reporting functions across R&D, clinical, manufacturing, and commercial divisions often with multi-entity, multi-currency complexity and strict cost allocation requirements for capitalisation, grant compliance, and investor reporting. Back-office automation eliminates manual overhead and improves financial data accuracy.
- Clinical trial cost accrual automation, calculating outstanding CRO, site, and investigator cost accruals based on milestones achieved and contract terms without manual estimation
- Purchase order and accounts payable automation, vendor invoice capture, three-way matching against CRO contracts and site agreements, and payment processing across clinical and commercial spend
- Grant and R&D tax credit compliance automation, tracking qualifying expenditures by project, compiling RDEC and patent box supporting data, and generating HMRC or IRS submission workpapers
- Milestone payment automation, monitoring CRO and CDO contract milestone achievement triggers and initiating payment workflows with appropriate financial approval routing
- Headcount and resource allocation reporting automation, aggregating FTE data across projects, generating capitalisation percentages, and producing quarterly R&D cost allocation reports
- Financial close and consolidation automation, aggregating trial balance data across legal entities, applying intercompany eliminations, and generating consolidated management accounts
Our Life Sciences Automation Approach
Our Approach
Our team carries deep expertise in GxP regulatory requirements, 21 CFR Part 11 electronic records compliance, ICH guideline frameworks, and the validated system integration standards that govern every automation decision in the life sciences sector. Every solution we deliver is designed to be audit-ready, inspection-ready, and compliant with applicable regulatory authority expectations from day one.
Phase 1 : Discovery & Process Assessment
We conduct a thorough assessment of your existing life sciences workflows across clinical operations, regulatory affairs, pharmacovigilance, manufacturing quality, and commercial functions identifying automation candidates by measuring process volume, error rates, handling time, and regulatory risk. The output is a prioritised automation roadmap with projected ROI for each opportunity, including GxP validation scope assessment and compliance risk classification.
Phase 2 : Solution Design & Architecture
Our automation architects design solutions using the optimal combination of RPA, Agentic AI, IDP, and workflow orchestration for each life sciences use case. We design for seamless, validated integration with your existing systems whether Veeva Vault, Medidata Rave, Oracle Clinical One, SAP S/4HANA, Oracle ERP, MasterControl, TrackWise, LIMS platforms, or proprietary validated systems with full consideration of 21 CFR Part 11 and GAMP 5 validation requirements.
Phase 3 : Development, Validation & Testing
Our certified automation developers build and rigorously test every life sciences automation solution with a validation-first approach. We produce complete validation documentation like IQ, OQ, PQ protocols, test scripts, and validation summary reports meeting GAMP 5 category requirements for each automated system. User acceptance testing with your clinical, regulatory, quality, and IT teams is a mandatory milestone before any validated go-live.
Phase 4 : Deployment & Hypercare
We deploy life sciences automations using a phased, change-controlled go-live approach managing organisational change across clinical operations, QA, and regulatory teams while maintaining GxP compliance throughout. A dedicated hypercare period immediately post-launch ensures rapid issue resolution, performance optimisation, and validation documentation updates before transitioning to steady-state operation.
Phase 5 : Ongoing Optimization & Governance
FDA and EMA regulations, ICH guidelines, and life sciences operating models evolve continuously. Our managed automation services keep your deployed solutions updated, revalidated where required, and continuously improved with real-time performance dashboards, SLA reporting, periodic review documentation, and proactive regulatory change management included as standard in every managed service agreement.
Benefits of Life Sciences Automation
Pharmaceutical companies, biotech firms, medical device manufacturers, and CROs that implement intelligent automation with Automate Stacks achieve compounding, measurable benefits across operational efficiency, regulatory compliance, data integrity, and time-to-market performance.
Accelerated Time-to-Market
Automation compresses cycle times across drug development, regulatory submissions, and manufacturing operations. Regulatory dossier compilation that required weeks of manual effort completes in days. Pharmacovigilance case processing that previously created regulatory deadline risk is completed well within expedited reporting windows and directly accelerating product approval timelines.
Operational Cost Reduction
Automating high-volume life sciences processes like adverse event data entry, clinical data queries, batch record processing, and regulatory tracking reduces the need for large operational teams performing repetitive manual tasks. Our clients achieve 40–70% cost savings in automated process areas, with automation paying back implementation investment within 12 months.
Enhanced Data Integrity & GxP Compliance
Human error in GxP-regulated data processing carries severe regulatory consequences like FDA warning letters, EMA inspection findings, and clinical hold risk. Automated processes execute with consistent validation logic, built-in audit trails, and exception-handling protocols that ensure data integrity across every automated workflow, every time.
Real-Time Regulatory Compliance
Life sciences automation enforces GxP, 21 CFR Part 11, ICH, and applicable regulatory requirements consistently across every data transaction and workflow. Audit trails are generated automatically, expedited reports are submitted within statutory windows, and regulatory teams are alerted to emerging compliance risks before they escalate to inspection findings.
Improved Clinical Operations Quality
Automating data query resolution, site performance monitoring, and protocol deviation tracking reduces the administrative burden on CRAs and data managers freeing clinical professionals for quality oversight, patient safety monitoring, and site relationship management activities that require human expertise and judgment.
Scalability Across Programmes & Pipeline
As drug pipelines grow and clinical programmes expand across geographies, automated systems scale elastically without proportional headcount increases. New trial starts, additional markets, and pipeline expansion are absorbed without compromising data quality, regulatory compliance, or operational performance enabling life sciences organisations to grow sustainably.
Life Sciences Segments We Serve
Our life sciences automation expertise spans every major segment of the pharmaceutical, biotechnology, medical device, and clinical research industry. Whether you are a global pharmaceutical company, an emerging biotech, a CRO, or a MedTech manufacturer, we have the domain expertise and GxP-compliant deployment track record your environment demands.
Don’t see your financial service sector?
This list is not comprehensive. Let us learn more and share our experience with your industry.
Frequently Asked Questions: Life Sciences Automation
What is life sciences automation?
Life sciences automation is the use of RPA, Agentic AI, machine learning, and intelligent document processing to automate manual and complex workflows across pharmaceutical, biotech, medical device, and clinical research organisations including clinical trial data management, regulatory submissions, pharmacovigilance case processing, manufacturing quality documentation, and supply chain operations without requiring human intervention at every step.
Is life sciences automation compliant with GxP and 21 CFR Part 11 requirements?
Yes. All Automate Stacks life sciences automation solutions are designed and implemented with GxP compliance and 21 CFR Part 11 electronic records requirements as foundational design principles. Every automated system is developed with full GAMP 5 validation documentation like IQ, OQ, and PQ protocols, test scripts, and validation summary reports and all automated workflows generate audit trails that meet FDA, EMA, and ICH data integrity expectations. We do not treat compliance as an afterthought; it is built into every solution from the architecture phase.
How does automation improve pharmacovigilance operations?
Pharmacovigilance automation transforms adverse event processing at every stage. Automated intake captures and structures incoming safety reports from multiple sources simultaneously. AI-assisted ICSR narrative generation and seriousness assessment support reduces case processing time by 60–80%. Automated regulatory submission workflows ensure expedited 15-day and 7-day reports are never missed. Aggregate report compilation automation eliminates the months of manual data gathering that currently precede PSUR and DSUR submissions. Our PV clients consistently achieve zero expedited reporting timeline breaches after automation deployment.
How long does it take to implement life sciences automation?
Implementation timelines in life sciences include a validation phase not present in non-GxP environments. Straightforward automations such as regulatory tracking dashboards or literature screening workflows can typically be deployed and validated in 6–10 weeks. Complex, validated multi-system workflows such as end-to-end pharmacovigilance case processing, clinical data query management, or manufacturing CAPA automation typically require 4–8 months for full validated deployment, including system design specification, GAMP validation documentation, and qualified user acceptance testing.
What ROI can life sciences organisations expect from automation?
Automate Stacks life sciences clients typically achieve 200–400% ROI within the first year of deployment, with 40–70% cost reductions in automated process areas, near-zero data entry error rates, and measurably faster processing across pharmacovigilance, regulatory affairs, and clinical operations. Regulatory submission automation and pharmacovigilance workflow automation frequently eliminate the resourcing costs of entire contractor teams, generating savings that substantially exceed the total automation investment cost within the first programme year.
Can life sciences automation integrate with validated systems like Veeva Vault and Medidata?
Yes. Automate Stacks has certified integration experience with the most widely deployed life sciences platforms like Veeva Vault (RIM, QualityDocs, CDMS, Safety), Medidata Rave and Rave CTMS, Oracle Clinical One, Oracle Argus Safety, ArisGlobal LifeSphere, IQVIA Pharmacovigilance Suite, MasterControl, TrackWise, SAP S/4HANA, and multiple LIMS and MES platforms. All implemented with the validated integration protocols required for GxP-regulated environments.
What is the difference between RPA and Agentic AI in life sciences automation?
RPA automates structured, rule-based life sciences tasks lie EDC data entry, regulatory submission uploads, batch record data extraction, and system-to-system data transfers by programmatically interacting with existing validated software. Agentic AI handles complexity and scientific judgment: generating adverse event narratives, assessing protocol deviations, responding to regulatory agency queries, and reasoning through signal detection outputs. Most enterprise life sciences automation programmes combine both RPA for high-volume, repeatable GxP data processing and AI for document-intensive, scientifically complex, and judgment-dependent workflows.
What clients say about our Financial Services Automation
